DoubleLine ETF Adviser LP Purchases New Position in Kenvue Inc. $KVUE

DoubleLine ETF Adviser LP acquired a new stake in shares of Kenvue Inc. (NYSE:KVUE) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 95,548 shares of the company’s stock, valued at approximately $1,551,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. AlphaCore Capital LLC grew its stake in Kenvue by 9.9% in the second quarter. AlphaCore Capital LLC now owns 5,287 shares of the company’s stock valued at $111,000 after acquiring an additional 476 shares during the period. Empirical Finance LLC increased its stake in Kenvue by 1.8% during the 2nd quarter. Empirical Finance LLC now owns 28,309 shares of the company’s stock worth $593,000 after purchasing an additional 491 shares in the last quarter. J.W. Cole Advisors Inc. raised its holdings in Kenvue by 3.8% during the 2nd quarter. J.W. Cole Advisors Inc. now owns 15,488 shares of the company’s stock worth $324,000 after buying an additional 574 shares during the period. Versor Investments LP lifted its stake in Kenvue by 2.8% in the third quarter. Versor Investments LP now owns 26,016 shares of the company’s stock valued at $422,000 after buying an additional 716 shares in the last quarter. Finally, Patton Fund Management Inc. boosted its holdings in shares of Kenvue by 8.1% in the third quarter. Patton Fund Management Inc. now owns 10,353 shares of the company’s stock valued at $168,000 after buying an additional 780 shares during the period. 97.64% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently commented on KVUE. Canaccord Genuity Group raised their price objective on shares of Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Wednesday, February 18th. Zacks Research upgraded Kenvue from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th. Argus upgraded Kenvue to a “hold” rating in a report on Friday, March 6th. Citigroup upped their price objective on Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 18th. Finally, UBS Group lifted their target price on Kenvue from $17.00 to $19.00 and gave the company a “neutral” rating in a research report on Wednesday, February 18th. Three research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $19.58.

Kenvue Stock Performance

Shares of KVUE stock opened at $17.51 on Friday. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $25.17. The company has a market capitalization of $33.55 billion, a price-to-earnings ratio of 22.73, a PEG ratio of 3.97 and a beta of 0.51. The company has a 50-day simple moving average of $17.89 and a 200 day simple moving average of $17.30. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.96.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. The company had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The business’s revenue was up 3.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.26 earnings per share. On average, sell-side analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were given a dividend of $0.2075 per share. The ex-dividend date was Wednesday, February 11th. This represents a $0.83 annualized dividend and a yield of 4.7%. Kenvue’s dividend payout ratio (DPR) is presently 107.79%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.